Montreal Heart Launches Simulation Centre

Why It Matters

By providing immersive, risk‑free training, the centre accelerates skill acquisition, standardizes practices and expands treatment capacity for a growing valve‑disease population, positioning MHI as a global leader in structural cardiology.

Key Takeaways

• First Americas hospital with advanced valve simulation centre.
• Aims to double valve patients treated by 2028.
• Trains 40‑50 international surgeons annually using high‑fidelity simulators.
• Partners include Simulands, Abbott, and MHI Foundation funding.
• Enhances precision, reduces risk in transcatheter valve procedures.

Pulse Analysis

Simulation technology is reshaping cardiovascular care as an aging population drives demand for minimally invasive valve therapies. High‑fidelity platforms replicate patient‑specific anatomy, tactile feedback and real‑time decision points, allowing clinicians to rehearse complex cases without exposing patients to risk. This hands‑on rehearsal shortens learning curves, improves procedural success rates, and aligns with precision‑medicine trends that prioritize individualized treatment pathways.

The Montreal Heart Institute’s new simulation centre integrates directly with its research and clinical workflows, creating a seamless pipeline from bench to bedside. By hosting international surgeons from Brazil, Puerto Rico and beyond, MHI extends its expertise globally, fostering a network of specialists who carry standardized, best‑practice techniques back to their home institutions. The centre’s capacity to train 40‑50 foreign clinicians annually amplifies its impact, effectively multiplying the institute’s patient‑care footprint across the Americas.

Industry partners Simulands and Abbott provide the cutting‑edge hardware and software that make the immersive experience possible, while the MHI Foundation’s philanthropic support underscores the model’s sustainability. As other hospitals observe MHI’s benchmark, adoption of similar simulation hubs is likely to accelerate, driving broader improvements in procedural safety and outcomes. In the long term, widespread simulation training could enable faster rollout of next‑generation transcatheter devices, cementing the role of virtual rehearsal as a cornerstone of cardiovascular education and innovation.